Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-29T17:51:48.618Z Has data issue: false hasContentIssue false

1 - Acute Viral Hepatitis

Published online by Cambridge University Press:  08 August 2009

Zobair M. Younossi
Affiliation:
Inova Fairfax Hospital, Annandale, VA
Get access

Summary

BACKGROUND

Acute viral hepatitis is a term that is generally given to the disease condition attributed to a group of viruses that have the propensity to infect the liver and cause necroinflammation. Although these hepatotropic viruses share a common clinical presentation, they belong to different virus families, have different modes of transmission, and differ in their propensity to lead to chronic infection (Table 1.1). Even as acute viral hepatitis remains an important public health prob- lem in the United States, it is noteworthy that there has been and continues to be a decline in the number of new infections of hepatitis A, B, and C (Table 1.2).

It is important to keep in mind that there are a number of conditions that can have a clinical presentation consistent with an acute hepatitis – elevated serum aminotransferases with variable elevations in bilirubin levels. Aside from the hepatotropic viruses, other viruses such as the herpes viruses can also lead to acute hepatitis. The differential diagnoses for acute hepatitis include alcoholic hepatitis, acute Budd-Chiari syndrome, drug-induced liver injury, shock liver, autoimmune hepatitis, biliary obstruction, and Wilson's disease (Table 1.3). A careful history and physical examination can usually point the clinician to the appropriate diagnostic evaluation to arrive at a correct diagnosis. This chapter will review the hepatotropic viruses – hepatitis A to E.

ACUTE HEPATITIS A

In 1973, Feinstone and colleagues first identified the hepatitis A virus (HAV) in the stool samples of normal volunteers who were infected with HAV and had developed acute hepatitis.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

,Centers for Disease Control. Disease Burden from Hepatitis A, B, and C in the Unites States. Volume 2006.
Feinstone, SM, Kapikian, AZ, Purceli, RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973;182: 1026–8.CrossRefGoogle ScholarPubMed
Martin, A, Lemon, SM. Hepatitis A virus: from discovery to vaccines. Hepatology 2006;43:S164–72.CrossRefGoogle ScholarPubMed
Costa-Mattioli, M, Di Napoli, A, Ferre, V, Billaudel, S, Perez-Bercoff, R, Cristina, J. Genetic variability of hepatitis A virus. J Gen Virol 2003;84:3191–201.CrossRefGoogle ScholarPubMed
Koff, RS. Hepatitis A. Lancet 1998;351:1643–9.CrossRefGoogle ScholarPubMed
Kemmer, NM, Miskovsky, EP. Hepatitis A. Infect Dis Clin North Am 2000;14:605–15.CrossRefGoogle ScholarPubMed
,Centers for Disease Control. Hepatitis Surveillance. Volume 2006.
Wasley, A, Fiore, A, Bell, BP. Hepatitis a in the era of vaccination. Epidemiol Rev 2006;28:101–11.CrossRefGoogle ScholarPubMed
Brundage, SC, Fitzpatrick, AN. Hepatitis A. Am Fam Physician 2006;73:2162–8.Google ScholarPubMed
Tong, MJ, el-Farra, NS, Grew, MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis 1995; 171 Suppl 1:S15–8.CrossRefGoogle Scholar
Schiff, ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992;10 Suppl 1: S18–20.Google ScholarPubMed
Romero, R, Lavine, JE. Viral hepatitis in children. Semin Liver Dis 1994;14:289–302.CrossRefGoogle ScholarPubMed
Ostapowicz, G, Fontana, RJ, Schiodt, FV, Larson, A, Davern, TJ, Han, SH, McCashland, TM, Shakil, AO, Hay, JE, Hynan, L, Crippin, JS, Blei, AT, Samuel, G, Reisch, J, Lee, WM. Results of a prospective study of acute liver failure at 17 tertiary care centers in theUnited States. Ann Intern Med 2002;137:947–54.CrossRefGoogle ScholarPubMed
Taylor, RM, Davern, T, Munoz, S, Han, SH, McGuire, B, Larson, AM, Hynan, L, Lee, WM, Fontana, RJ. Fulminant hepatitis A virus infection in theUnited States: Incidence, prognosis, and outcomes. Hepatology 2006;44:1589–97.Google ScholarPubMed
Gordon, SC, Reddy, KR, Schiff, L, Schiff, ER. Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann Intern Med 1984;101:635–7.CrossRefGoogle ScholarPubMed
Glikson, M, Galun, E, Oren, R, Tur-Kaspa, R, Shouval, D. Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine (Baltimore) 1992;71:14–23.CrossRefGoogle ScholarPubMed
Sciot, R, Damme, B, Desmet, VJ. Cholestatic features in hepatitis A. J Hepatol 1986;3:172–81.CrossRefGoogle ScholarPubMed
Vallbracht, A, Maier, K, Stierhof, YD, Wiedmann, KH, Flehmig, B, Fleischer, B. Liver-derived cytotoxic T cells in hepatitis A virus infection. J Infect Dis 1989;160:209–17.CrossRefGoogle ScholarPubMed
Davis, JP. Experience with hepatitis A and B vaccines. Am J Med 2005;118 Suppl 10A:7S-15S.CrossRefGoogle ScholarPubMed
,Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45:1–30.Google Scholar
,Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48:1–37.Google Scholar
Fiore, AE, Wasley, A, Bell, BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1–23.Google Scholar
Akriviadis, EA, Redeker, AG. Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med 1989;110:838–9.CrossRefGoogle ScholarPubMed
Vento, S, Garofano, T, Renzini, C, Cainelli, F, Casali, F, Ghironzi, G, Ferraro, T, Concia, E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286–90.CrossRefGoogle ScholarPubMed
Keeffe, EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995;90:201–5.Google ScholarPubMed
Perrillo, RP. Current treatment of chronic hepatitis B: benefits and limitations. Semin Liver Dis 2005;25 Suppl 1:20–8.CrossRefGoogle ScholarPubMed
Werle-Lapostolle, B, Bowden, S, Locarnini, S, Wursthorn, K, Petersen, J, Lau, G, Trepo, C, Marcellin, P, Goodman, Z, Delaney, WEt, Xiong, S, Brosgart, CL, Chen, SS, Gibbs, CS, Zoulim, F. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004;126:1750–8.CrossRefGoogle ScholarPubMed
Locarnini, S. Molecular virology and the development of resistant mutants: implications for therapy. Semin Liver Dis 2005;25 Suppl 1:9–19.CrossRefGoogle ScholarPubMed
Schaefer, S. Hepatitis B virus: significance of genotypes. J Viral Hepat 2005;12: 111–24.CrossRefGoogle ScholarPubMed
Chu, CJ, Keeffe, EB, Han, SH, Perrillo, RP, Min, AD, Soldevila-Pico, C, Carey, W, BrownRS, Jr. RS, Jr., Luketic, VA, Terrault, N, Lok, AS. Hepatitis B virus genotypes in theUnited States: results of a nationwide study. Gastroenterology 2003;125:444–51.Google ScholarPubMed
Fung, SK, Lok, AS. Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 2004;40:790–2.CrossRefGoogle ScholarPubMed
Garfein, RS, Bower, WA, Loney, CM, Hutin, YJ, Xia, GL, Jawanda, J, Groom, AV, Nainan, OV, Murphy, JS, Bell, BP. Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology 2004;40:865–73.CrossRefGoogle ScholarPubMed
Wai, CT, Fontana, RJ, Polson, J, Hussain, M, Shakil, AO, Han, SH, Davern, TJ, Lee, WM, Lok, AS. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat 2005;12:192–8.CrossRefGoogle ScholarPubMed
Lavanchy, D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107.CrossRefGoogle ScholarPubMed
Alter, MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis 2003;23:39–46.CrossRefGoogle ScholarPubMed
McQuillan, GM, Coleman, PJ, Kruszon-Moran, D, Moyer, , Lambert, SB, Margolis, HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89:14–8.CrossRefGoogle ScholarPubMed
Goldstein, ST, Alter, MJ, Williams, IT, Moyer, , Judson, FN, Mottram, K, Fleenor, M, Ryder, PL, Margolis, HS. Incidence and risk factors for acute hepatitis B in the United States, 1982–1998: implications for vaccination programs. J Infect Dis 2002;185:713–9.CrossRefGoogle ScholarPubMed
McMahon, BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005;25 Suppl 1:3–8.CrossRefGoogle Scholar
Ganem, D, Prince, AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med 2004;350:1118–29.CrossRefGoogle ScholarPubMed
Zuckerman, AJ. Prevention of primary liver cancer by immunization. N Engl J Med 1997;336:1906–7.CrossRefGoogle ScholarPubMed
Chang, MH, Chen, CJ, Lai, MS, Hsu, HM, Wu, TC, Kong, MS, Liang, DC, Shau, WY, Chen, DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855–9.CrossRefGoogle ScholarPubMed
Mast, EE, Margolis, HS, Fiore, AE, Brink, EW, Goldstein, ST, Wang, SA, Moyer, , Bell, BP, Alter, MJ. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54:1–31.Google ScholarPubMed
Mast, EE, Weinbaum, CM, Fiore, AE, Alter, MJ, Bell, BP, Finelli, L, Rodewald, , DouglasJM, Jr. JM, Jr., Janssen, RS, Ward, JW. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006;55:1–33; quiz C E1–4.Google ScholarPubMed
Schmilovitz-Weiss, H, Ben-Ari, Z, Sikuler, E, Zuckerman, E, Sbeit, W, Ackerman, Z, Safadi, R, Lurie, Y, Rosner, G, Tur-Kaspa, R, Reshef, R. Lamivudine treatment for acute severe hepatitis B: a pilot study. Liver Int 2004;24:547–51.CrossRefGoogle ScholarPubMed
Torii, N, Hasegawa, K, Ogawa, M, Hashimo, E, Hayashi, N. Effectiveness and long-term outcome of lamivudine therapy for acute hepatitis B. Hepatol Res 2002;24:34.CrossRefGoogle ScholarPubMed
Kondili, , Osman, H, Mutimer, D. The use of lamivudine for patients with acute hepatitis B (a series of cases). J Viral Hepat 2004;11:427–31.CrossRefGoogle Scholar
Tillmann, HL, Hadem, J, Leifeld, L, Zachou, K, Canbay, A, Eisenbach, C, Graziadei, I, Encke, J, Schmidt, H, Vogel, W, Schneider, A, Spengler, U, Gerken, G, Dalekos, GN, Wedemeyer, H, Manns, MP. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006;13:256–63.CrossRefGoogle ScholarPubMed
Tassopoulos, NC, Koutelou, MG, Polychronaki, H, Paraloglou-Ioannides, M, Hadziyannis, SJ. Recombinant interferon-alpha therapy for acute hepatitis B: a randomized, double-blind, placebo-controlled trial. J Viral Hepat 1997;4:387–94.CrossRefGoogle ScholarPubMed
Davis, GL, Albright, JE, Cook, SF, Rosenberg, DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331–8.CrossRefGoogle ScholarPubMed
Lauer, GM, Walker, BD. Hepatitis C virus infection. N Engl J Med 2001;345:41–52.CrossRefGoogle ScholarPubMed
Thomson, BJ, Finch, RG. Hepatitis C virus infection. Clin Microbiol Infect 2005;11:86–94.CrossRefGoogle ScholarPubMed
Carey, W. Tests and screening strategies for the diagnosis of hepatitis C. Cleve Clin J Med 2003;70 Suppl 4:S7–13.CrossRefGoogle Scholar
Armstrong, GL, Wasley, A, Simard, EP, McQuillan, GM, Kuhnert, WL, Alter, MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705–14.CrossRefGoogle ScholarPubMed
Armstrong, GL, Alter, MJ, McQuillan, GM, Margolis, HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31:777–82.CrossRefGoogle ScholarPubMed
Williams, I. Epidemiology of hepatitis C in the United States. Am J Med 1999;107:2S-9S.CrossRefGoogle ScholarPubMed
Alter, MJ. Prevention of spread of hepatitis C. Hepatology 2002;36:S93–8.Google ScholarPubMed
Zein, NN. The epidemiology and natural history of hepatitis C virus infection. Cleve Clin J Med 2003;70 Suppl 4:S2–6.CrossRefGoogle ScholarPubMed
Mondelli, MU, Cerino, A, Cividini, A. Acute hepatitis C: diagnosis and management. J Hepatol 2005;42 Suppl:S108–14.CrossRefGoogle ScholarPubMed
Irving, WL. Acute hepatitis C virus infection: a neglected disease?Gut 2006;55:1075–7.CrossRefGoogle ScholarPubMed
Pawlotsky, JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002;36:S65–73.Google ScholarPubMed
Farci, P, Alter, HJ, Shimoda, A, Govindarajan, S, Cheung, LC, Melpolder, JC, Sacher, RA, Shih, JW, Purcell, RH. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med 1996;335:631–4.CrossRefGoogle ScholarPubMed
Hoofnagle, JH. Course and outcome of hepatitis C. Hepatology 2002;36:S21–9.Google ScholarPubMed
Micallef, JM, Kaldor, JM, Dore, GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006;13:34–41.CrossRefGoogle ScholarPubMed
Thomas, DL, Astemborski, J, Rai, RM, Anania, FA, Schaeffer, M, Galai, N, Nolt, K, Nelson, KE, Strathdee, SA, Johnson, L, Laeyendecker, O, Boitnott, J, Wilson, , Vlahov, D. The natural history of hepatitis C virus infection: host, viral, and environmental factors. Jama 2000;284:450–6.CrossRefGoogle ScholarPubMed
Farci, P, Shimoda, A, Coiana, A, Diaz, G, Peddis, G, Melpolder, JC, Strazzera, A, Chien, DY, Munoz, SJ, Balestrieri, A, Purcell, RH, Alter, HJ. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000;288:339–44.CrossRefGoogle ScholarPubMed
Heller, T, Rehermann, B. Acute hepatitis C: a multifaceted disease. Semin Liver Dis 2005;25:7–17.CrossRefGoogle ScholarPubMed
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep 2001;50:1–52.
,National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002– June 10–12, 2002. Hepatology 2002;36:S3–20.CrossRefGoogle Scholar
Santantonio, T, Sinisi, E, Guastadisegni, A, Casalino, C, Mazzola, M, Gentile, A, Leandro, G, Pastore, G. Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 2003;35:104–13.CrossRefGoogle ScholarPubMed
Licata, A, Di Bona, D, Schepis, F, Shahied, L, Craxi, A, Camma, C. When and how to treat acute hepatitis C?J Hepatol 2003;39:1056–62.CrossRefGoogle ScholarPubMed
Kamal, SM, Fouly, AE, Kamel, RR, Hockenjos, B, Al Tawil, A, Khalifa, KE, He, Q, Koziel, MJ, El Naggar, KM, Rasenack, J, Afdhal, NH. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology 2006;130:632–8.CrossRefGoogle ScholarPubMed
Wiegand, J, Buggisch, P, Boecher, W, Zeuzem, S, Gelbmann, CM, Berg, T, Kauffmann, W, Kallinowski, B, Cornberg, M, Jaeckel, E, Wedemeyer, H, Manns, MP. Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology 2006;43:250–6.CrossRefGoogle ScholarPubMed
Santantonio, T, Fasano, M, Sinisi, E, Guastadisegni, A, Casalino, C, Mazzola, M, Francavilla, R, Pastore, G. Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. J Hepatol 2005;42:329–33.CrossRefGoogle ScholarPubMed
Kamal, SM, Moustafa, KN, Chen, J, Fehr, J, Abdel Moneim, A, Khalifa, KE, El Gohary, , Ramy, AH, Madwar, MA, Rasenack, J, Afdhal, NH. Duration of peginterferon therapy in acute hepatitis C: a randomized trial. Hepatology 2006;43:923–31.CrossRefGoogle ScholarPubMed
Kamal, SM, El Tawil, AA, Nakano, T, He, Q, Rasenack, J, Hakam, SA, Saleh, WA, Ismail, A, Aziz, AA, Madwar, MA. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response. Gut 2005;54:858–66.CrossRefGoogle ScholarPubMed
Strader, DB, Wright, T, Thomas, DL, Seeff, LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147–71.CrossRefGoogle ScholarPubMed
Rizzetto, M, Canese, MG, Arico, S, Crivelli, O, Trepo, C, Bonino, F, Verme, G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18:997–1003.CrossRefGoogle ScholarPubMed
Wang, KS, Choo, QL, Weiner, AJ, Ou, JH, Najarian, RC, Thayer, RM, Mullenbach, GT, Denniston, KJ, Gerin, JL, Houghton, M. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature 1986;323:508–14.CrossRefGoogle ScholarPubMed
Radjef, N, Gordien, E, Ivaniushina, V, Gault, E, Anais, P, Drugan, T, Trinchet, JC, Roulot, D, Tamby, M, Milinkovitch, MC, Deny, P. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004;78:2537–44.CrossRefGoogle ScholarPubMed
Farci, P. Delta hepatitis: an update. J Hepatol 2003;39 Suppl 1:S212–9.CrossRefGoogle ScholarPubMed
Gaeta, GB, Stroffolini, T, Chiaramonte, M, Ascione, T, Stornaiuolo, G, Lobello, S, Sagnelli, E, Brunetto, MR, Rizzetto, M. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology 2000;32:824–7.CrossRefGoogle ScholarPubMed
Sagnelli, E, Stroffolini, T, Ascione, A, Chiaramonte, M, Craxi, A, Giusti, G, Piccinino, F. Decrease in HDV endemicity in Italy. J Hepatol 1997;26:20–4.CrossRefGoogle ScholarPubMed
Manock, SR, Kelley, PM, Hyams, KC, Douce, R, Smalligan, RD, Watts, DM, Sharp, TW, Casey, JL, Gerin, JL, Engle, R, Alava-Alprecht, A, Martinez, CM, Bravo, NB, Guevara, AG, Russell, KL, Mendoza, W, Vimos, C. An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. Am J Trop Med Hyg 2000;63:209–13.CrossRefGoogle ScholarPubMed
Flodgren, E, Bengtsson, S, Knutsson, M, Strebkova, EA, Kidd, AH, Alexeyev, OA, Kidd-Ljunggren, K. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol 2000;38:3311–6.Google ScholarPubMed
Wu, JC, Chen, CM, Sheen, IJ, Lee, SD, Tzeng, HM, Choo, KB. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology 1995;22:1656–60.Google ScholarPubMed
Niro, GA, Casey, JL, Gravinese, E, Garrubba, M, Conoscitore, P, Sagnelli, E, Durazzo, M, Caporaso, N, Perri, F, Leandro, G, Facciorusso, D, Rizzetto, M, Andriulli, A. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol 1999;30:564–9.CrossRefGoogle ScholarPubMed
Guilhot, S, Huang, SN, Xia, YP, Monica, N, Lai, MM, Chisari, FV. Expression of the hepatitis delta virus large and small antigens in transgenic mice. J Virol 1994;68:1052–8.Google ScholarPubMed
Cole, SM, Gowans, EJ, Macnaughton, TB, Hall, PD, Burrell, CJ. Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen. Hepatology 1991;13:845–51.CrossRefGoogle ScholarPubMed
Nisini, R, Paroli, M, Accapezzato, D, Bonino, F, Rosina, F, Santantonio, T, Sallusto, F, Amoroso, A, Houghton, M, Barnaba, V. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol 1997;71:2241–51.Google ScholarPubMed
Farci, P, Mandas, A, Coiana, A, Lai, ME, Desmet, V, Eyken, P, Gibo, Y, Caruso, L, Scaccabarozzi, S, Criscuolo, D, et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994;330:88–94.CrossRefGoogle ScholarPubMed
Lau, DT, Kleiner, , Park, Y, Di Bisceglie, AM, Hoofnagle, JH. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. Gastroenterology 1999;117:1229–33.CrossRefGoogle ScholarPubMed
Lau, DT, Doo, E, Park, Y, Kleiner, , Schmid, P, Kuhns, MC, Hoofnagle, JH. Lamivudine for chronic delta hepatitis. Hepatology 1999;30:546–9.CrossRefGoogle ScholarPubMed
Wong, DC, Purcell, RH, Sreenivasan, MA, Prasad, SR, Pavri, KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet 1980;2:876–9.CrossRefGoogle ScholarPubMed
Khuroo, MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980;68:818–24.CrossRefGoogle ScholarPubMed
Balayan, MS, Andjaparidze, AG, Savinskaya, SS, Ketiladze, ES, Braginsky, DM, Savinov, AP, Poleschuk, VF. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983;20:23–31.Google ScholarPubMed
Tam, AW, Smith, MM, Guerra, ME, Huang, CC, Bradley, DW, Fry, KE, Reyes, GR. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120–31.CrossRefGoogle ScholarPubMed
Reyes, GR, Purdy, MA, Kim, JP, Luk, KC, Young, LM, Fry, KE, Bradley, DW. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335–9.CrossRefGoogle ScholarPubMed
Jameel, S.Molecular biology and pathogenesis of hepatitis E virus. Expert Rev Mol Med 1999;1999:1–16.Google ScholarPubMed
Schlauder, GG, Mushahwar, IK. Genetic heterogeneity of hepatitis E virus. J Med Virol 2001;65:282–92.CrossRefGoogle ScholarPubMed
Wang, L, Zhuang, H. Hepatitis E: an overview and recent advances in vaccine research. World J Gastroenterol 2004;10:2157–62.CrossRefGoogle ScholarPubMed
Krawczynski, K. Hepatitis E. Hepatology 1993;17:932–41.CrossRefGoogle ScholarPubMed
Krawczynski, K, Aggarwal, R, Kamili, S.Hepatitis E. Infect Dis Clin North Am 2000;14:669–87.CrossRef
Aggarwal, R, Naik, SR. Hepatitis E: intrafamilial transmission versus waterborne spread. J Hepatol 1994;21:718–23.CrossRefGoogle ScholarPubMed
Khuroo, MS, Kamili, S, Jameel, S. Vertical transmission of hepatitis E virus. Lancet 1995;345:1025–6.CrossRefGoogle ScholarPubMed
Teo, CG. Hepatitis E indigenous to economically developed countries: to what extent a zoonosis? Curr Opin Infect Dis 2006;19:460–6.CrossRefGoogle ScholarPubMed
Khuroo, MS, Rustgi, VK, Dawson, GJ, Mushahwar, IK, Yattoo, GN, Kamili, S, Khan, BA. Spectrum of hepatitis E virus infection in India. J Med Virol 1994;43:281–6.CrossRefGoogle ScholarPubMed
Khuroo, MS, Teli, MR, Skidmore, S, Sofi, MA, Khuroo, MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252–5.CrossRefGoogle ScholarPubMed
Hamid, SS, Atiq, M, Shehzad, F, Yasmeen, A, Nissa, T, Salam, A, Siddiqui, A, Jafri, W. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002;36:474–8.CrossRefGoogle ScholarPubMed
Khuroo, MS, Kamili, S, Dar, MY, Moecklii, R, Jameel, S. Hepatitis E and long-term antibody status. Lancet 1993;341:1355.Google ScholarPubMed
Arankalle, VA, Chadha, MS, Dama, BM, Tsarev, SA, Purcell, RH, Banerjee, K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepat 1998;5:199–204.CrossRefGoogle ScholarPubMed
Khuroo, MS, Dar, MY. Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992;11:113–6.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×